
    
      Women with mixed incontinence with primary stress symptoms undergoing Sub-Urethral Sling
      Procedures will be randomized to peri-operative placebo or solifenacin. Subjects in the
      placebo group will take orally once daily for 9 weeks. Subjects in the Solifenacin group will
      take orally once daily for 9 weeks.
    
  